These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1872020)

  • 1. Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.
    Cooper PD; Steele EJ
    Vaccine; 1991 May; 9(5):351-7. PubMed ID: 1872020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adjuvants based on gamma inulin.
    Cooper PD
    Pharm Biotechnol; 1995; 6():559-80. PubMed ID: 7551236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice.
    Cooper PD; Turner R; McGovern J
    Immunol Lett; 1991 Feb; 27(2):131-4. PubMed ID: 1827427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjuvanticity of Algammulin, a new vaccine adjuvant.
    Cooper PD; McComb C; Steele EJ
    Vaccine; 1991 Jun; 9(6):408-15. PubMed ID: 1887671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of gamma inulin and Algammulin on the immune response in sheep to a recombinant antigen of Taenia ovis.
    Deol HS; Palmer DG; Dunsmore T; Carnegie PR
    Vaccine; 1995 Apr; 13(5):429-33. PubMed ID: 7639010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-complementary action of polymorphic "solubility forms" of particulate inulin.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):895-901. PubMed ID: 3796631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines.
    Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.
    Cooper PD; Petrovsky N
    Glycobiology; 2011 May; 21(5):595-606. PubMed ID: 21147758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.
    Mahalakshmi N; Aparnaa R; Kaliraj P
    Scand J Immunol; 2014 Oct; 80(4):261-70. PubMed ID: 25041426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses.
    Silva DG; Cooper PD; Petrovsky N
    Immunol Cell Biol; 2004 Dec; 82(6):611-6. PubMed ID: 15550119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system.
    Kumar S; Tummala H
    Mol Pharm; 2013 May; 10(5):1845-53. PubMed ID: 23506468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.
    Petrovsky N
    Vaccine; 2006 Apr; 24 Suppl 2(Suppl 2):S2-26-9. PubMed ID: 16823913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural Visualization of Vaccine Adjuvant Uptake In Vitro and In Vivo.
    Giusti F; Seubert A; Cantisani R; Tortoli M; D'Oro U; Ferlenghi I; Dallai R; Piccioli D
    Microsc Microanal; 2015 Aug; 21(4):791-5. PubMed ID: 26223548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice.
    Harris SJ; Woodrow SA; Gearing AJ; Adams SE; Kingsman AJ; Layton GT
    Vaccine; 1996 Jul; 14(10):971-6. PubMed ID: 8873390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory properties of the vaccine adjuvant alum.
    Oleszycka E; Lavelle EC
    Curr Opin Immunol; 2014 Jun; 28():1-5. PubMed ID: 24463269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
    Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
    Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.
    Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ
    Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjuvanticity of gamma inulin.
    Cooper PD; Steele EJ
    Immunol Cell Biol; 1988; 66 ( Pt 5-6)():345-52. PubMed ID: 3265692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.